Skip to main content
Log in


Progressive multifocal leukoencephalopathy: case report

Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions


  • Auer M, et al. Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) and Natalizumab Serum Concentration as Potential Biomarkers for Pharmacodynamics and Treatment Response of Patients with Multiple Sclerosis Receiving Natalizumab. CNS Drugs 36: 1121-1131, No. 10, Oct 2022. Available from: URL:

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Natalizumab. Reactions Weekly 1940, 338 (2023).

Download citation

  • Published:

  • Issue Date:

  • DOI: